Research Article

Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory

Table 2

Baseline characteristics of 62 TB/HIV coinfected patients from Minsk, Belarus, stratified according to availability of Mycobacterium tuberculosis (Mtb) culture sample.

TotalSample yes, (%)Sample no, (%)
3032

GenderMale, (%)22 (73)28 (88)0.206
AgeYears, median (IQR)37 (30-41)35 (32-42)0.789
TB/HIV risk factorsEver injecting drug use, (%)19 (63)24 (75)0.319
History of imprisonment, (%)5 (17)12 (38)0.090
History of excess alcohol consumption, (%)19 (63)15 (47)0.213
Mtb culture positiveYes, (%)30 (100)25 (78)0.0015
MDR-TBYes, (%)18 (60)16 (50)0.456
TB diseaseDisseminated, (%)12 (40)6 (19)0.060
Hepatitis CEver, (%)24 (80)23 (72)0.454
HIV duration prior to TBMonths, median (IQR)88 (44-136)67 (25-120)0.535
Antiretroviral therapy at baselineYes, (%)15 (50)14 (44)0.622
CD4 countCells/mm3, median (IQR)85 (22-171)126 (57-310)0.097

Abbreviations: baseline = date of TB diagnosis; IQR = interquartile range; = number; MDR-TB = multidrug-resistant TB; Mtb = Mycobacterium tuberculosis; TB = tuberculosis; Hepatitis C antibody positive.